If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.958    -0.002 (-0.21%)
Bid:
0.958
Ask:
0.962
Spread: 0.004 (0.418%)
Market Cap: $1.08b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Holding(s) in Company

12 Apr 2021 11:00

RNS Number : 1386V
BioPharma Credit PLC
12 April 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDGKMY29

Issuer Name

BIOPHARMA CREDIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Newton Investment Management Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Is the shareholder the same as the person subject to the notification obligation, above?

Yes

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2021

6. Date on which Issuer notified

09-Apr-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.926571

0.000000

9.926571

136378417

Position of previous notification (if applicable)

10.02

N/A

10.02

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

CLASS/TYPE OF SHARES ISIN CODE(IF POSSIBLE)

NUMBER OF DIRECT VOTING RIGHTS (DTR5.1)

NUMBER OF INDIRECT VOTING RIGHTS (DTR5.2.1)

% OF DIRECT VOTING RIGHTS (DTR5.1)

% OF INDIRECT VOTING RIGHTS (DTR5.2.1)

GB00BDGKMY29

136378417

9.926571

Sub Total 8.A

136378417

9.926571%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

NUMBER OF VOTING RIGHTS THAT MAY BE ACQUIRED IF THE INSTRUMENT IS EXERCISED/CONVERTED

% OF VOTING RIGHTS

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

PHYSICAL OR CASH SETTLEMENT

NUMBER OF VOTING RIGHTS

% OF VOTING RIGHTS

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate Controlling Person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Is there proxy voting?

No

Name of the proxy holder

 

The number and % of voting rights held

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

09-Apr-2021

13. Place Of Completion

Uniondale, New York

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUUSKRAWUSARR
Date   Source Headline
2nd Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSTRIGGER OF A CONTINUATION RESOLUTION
31st Oct 20233:30 pmRNSDirector Declaration
24th Oct 20237:00 amRNSUPDATE ON INVESTMENT
20th Oct 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Oct 20237:00 amRNSUPDATE ON INVESTMENT
2nd Oct 20231:32 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSHalf-year Report
26th Sep 202311:20 amRNSUPDATE ON INVESTMENT
22nd Sep 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Sep 20237:00 amRNSUpdate on Investment
31st Aug 20237:00 amRNSNotice of Half Year Results
29th Aug 202311:25 amRNSUpdate on Investment
23rd Aug 20234:30 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Aug 20237:00 amRNSDividend Declaration
1st Aug 202311:29 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSSTATEMENT RE REATA PHARMACEUTICALS
21st Jul 20234:00 pmRNSNet Asset Value(s)
21st Jul 202311:30 amRNSUPDATE ON INVESTMENT
18th Jul 20237:00 amRNSUPDATE ON INVESTMENT
11th Jul 20236:15 pmRNSTransaction in Own Shares
10th Jul 20236:15 pmRNSTransaction in Own Shares
3rd Jul 20231:34 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSUpdate on Investment
30th Jun 20236:15 pmRNSTransaction in Own Shares
29th Jun 20236:15 pmRNSTransaction in Own Shares
26th Jun 20236:15 pmRNSTransaction in Own Shares
22nd Jun 20236:15 pmRNSTransaction in Own Shares
21st Jun 20234:00 pmRNSNet Asset Value(s)
20th Jun 20236:15 pmRNSTransaction in Own Shares
15th Jun 20236:15 pmRNSTransaction in Own Shares
13th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20237:00 amRNSUPDATE ON INVESTMENT
7th Jun 20236:15 pmRNSTransaction in Own Shares
6th Jun 20236:15 pmRNSTransaction in Own Shares
1st Jun 202312:04 pmRNSTotal Voting Rights
31st May 20236:15 pmRNSTransaction in Own Shares
30th May 20233:08 pmRNSResult of AGM
26th May 20236:15 pmRNSTransaction in Own Shares
25th May 20236:15 pmRNSTransaction in Own Shares
24th May 20236:15 pmRNSTransaction in Own Shares
23rd May 20236:15 pmRNSTransaction in Own Shares
23rd May 20234:00 pmRNSNet Asset Value(s)
19th May 20236:15 pmRNSTransaction in Own Shares
19th May 20237:00 amRNSUpdate on Investment
18th May 20236:15 pmRNSTransaction in Own Shares
16th May 20233:40 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSNEW INVESTMENT OF UP TO US$137.5 MILLION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.